Literature DB >> 16170145

Complex I respiratory defect in LHON plus dystonia with no mitochondrial DNA mutation.

K K Abu-Amero, T M Bosley, S Bohlega, D McLean.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170145      PMCID: PMC1772879          DOI: 10.1136/bjo.2005.072819

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Mitochondrial genome variation in eastern Asia and the peopling of Japan.

Authors:  Masashi Tanaka; Vicente M Cabrera; Ana M González; José M Larruga; Takeshi Takeyasu; Noriyuki Fuku; Li-Jun Guo; Raita Hirose; Yasunori Fujita; Miyuki Kurata; Ken-ichi Shinoda; Kazuo Umetsu; Yoshiji Yamada; Yoshiharu Oshida; Yuzo Sato; Nobutaka Hattori; Yoshikuni Mizuno; Yasumichi Arai; Nobuyoshi Hirose; Shigeo Ohta; Osamu Ogawa; Yasushi Tanaka; Ryuzo Kawamori; Masayo Shamoto-Nagai; Wakako Maruyama; Hiroshi Shimokata; Ryota Suzuki; Hidetoshi Shimodaira
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

2.  Mitochondrial T9957C mutation in association with NAION and seizures but not MELAS.

Authors:  Khaled K Abu-Amero; Thomas M Bosley; Saeed Bohlega; Erik Hansen
Journal:  Ophthalmic Genet       Date:  2005-03       Impact factor: 1.803

3.  Flow cytometry in the study of mitochondrial respiratory chain disorders.

Authors:  Karen Setterfield; Andrew J Williams; Jennifer Donald; David R Thorburn; Denise M Kirby; Ian Trounce; John Christodoulou
Journal:  Mitochondrion       Date:  2002-05       Impact factor: 4.160

4.  Complex I function in familial and sporadic dystonia.

Authors:  A H Schapira; T Warner; M T Gash; M W Cleeter; C F Marinho; J M Cooper
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

5.  Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation.

Authors:  Mark A Tarnopolsky; Steven K Baker; Tomoko Myint; C E Maxner; J Robitaille; Brian H Robinson
Journal:  Am J Med Genet A       Date:  2004-02-01       Impact factor: 2.802

6.  Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy.

Authors:  E K Nikoskelainen; R J Marttila; K Huoponen; V Juvonen; T Lamminen; P Sonninen; M L Savontaus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

Review 7.  Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene.

Authors:  Johannes Binder; Sabine Hofmann; Stefan Kreisel; Johannes C Wöhrle; Hansjörg Bäzner; Joachim K Krauss; Michael G Hennerici; Matthias F Bauer
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

  7 in total
  6 in total

1.  Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to Bedside.

Authors:  Rajeshwari D Koilkonda; John Guy
Journal:  J Ophthalmol       Date:  2010-12-26       Impact factor: 1.909

2.  Leber's Hereditary Optic Neuropathy: The Mitochondrial Connection Revisited.

Authors:  Khaled K Abu-Amero
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

3.  An overview of the Prince Salman Center for Disability Research scientific outcomes.

Authors:  Ali N Al-Odaib; Sultan T Al-Sedairy
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

4.  Visual and neurologic sequelae of methanol poisoning in Saudi Arabia.

Authors:  Alberto Galvez-Ruiz; Sahar M Elkhamary; Nasira Asghar; Thomas M Bosley
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

Review 5.  The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy.

Authors:  Yong Zhang; Zhen Tian; Jiajia Yuan; Chang Liu; Hong Li Liu; Si Qi Ma; Bin Li
Journal:  Curr Gene Ther       Date:  2017       Impact factor: 4.391

6.  An evaluation of genetic causes and environmental risks for bilateral optic atrophy.

Authors:  Andrew T Chen; Lauren Brady; Dennis E Bulman; Arun N E Sundaram; Amadeo R Rodriguez; Edward Margolin; John S Waye; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.